secwatch.observer — SEC 8-K summary
======================================

Issuer:     AIM ImmunoTech Inc. (AIM)
CIK:        0000946644
Form:       8-K
Filed at:   2025-02-26T23:59:59+00:00
Accession:  0001493152-25-008282
Event type: leadership
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02, 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

AIM ImmunoTech appoints David Chemerow as independent director; reduces stockholder meeting quorum to 33 1/3%
--------------------------------------------------------------------------------

- David Chemerow appointed as independent director, effective February 24, 2025.
- Chemerow brings 40+ years of finance, accounting, and operations leadership experience; former CFO of Comscore.
- Bylaws amended to reduce quorum for stockholder meetings from 40% to 33 1/3%.
- Chemerow will be compensated same as other directors; serves until 2025 Annual Meeting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/946644/000149315225008282/0001493152-25-008282-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/946644/000149315225008282/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-008282

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer